Posted on 30 January 2013.
The outlook for Amgen
Once oral dialysis drugs like Amgen's Sensipar, used to treat hyperparathyroidism, are included in the dialysis payment bundle, it is unlikely that the inevitable drop in sales will match what the biotech firm has seen from its anemia drugs. Although …
Full News here – Read more on NephrologyNews.com (blog)